Plus Therapeutics draws $3.3M from Pershing facility to repay Oxford term loan in full

PLUS THERAPEUTICS, INC.

Drew $3.3M from Pershing margin loan facility at FOMC target (floor 5.5%) + 1.75% spread + 0.5% fees, max Prime+3%.
On June 3, 2024, used the draw to repay and terminate the Oxford Finance term loan, totaling approx. $3.3M.
Repayment eliminated Oxford's security interest in all of Plus Therapeutics' assets and related covenants.
Pershing credit line is secured by collateralized marketable securities; can draw up to 91.5% of collateral value.
Outstanding balance is due on demand; Pershing may require additional collateral or liquidate securities upon default.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.